Anita Roberts Lecture - Advancing the Development of Effective Therapies for Children and Adults with Rare Tumors
Anita Roberts Lecture 2022
The “ Distinguished Women Scientists at NIH ” lecture series highlights the outstanding research achievements of woman scientists in the NIH Intramural Research Program. This seminar is dedicated to Dr. Anita Roberts and honors her role as an exceptional mentor and scientist.
Dr. Widemann is the Chief of the Pediatric Oncology Branch at NCI where she oversees basic, translational, and clinical research programs for children and young adults with hematologic and solid malignancies. Her research has been focused on drug development and early clinical trials for children with refractory solid tu...
Source: Videocast - All Events - September 26, 2022 Category: General Medicine Tags: Upcoming Events Source Type: video
Demystifying Medicine: Neurofibromatosis Type 1 related Tumors: From Natural History to Precision Therapy
Jointly sponsored by FAES and NIH, the Demystifying Medicine course aims to bridge exciting developments in medicine with advances in the basic biological and engineering sciences. When possible, a live patient introduces the course topic by discussing their disease, followed by a physician scientist who describes clinical aspects of the disease including therapy and challenges, followed by bench scientist who describes what we know and don't know regarding mechanism. The course is designed to excite as well as inform medical and Ph.D. students, fellows, basic and physician scientists, and program planners.For more informa...
Source: Videocast - All Events - March 24, 2022 Category: General Medicine Tags: Upcoming Events Source Type: video
Demystifying Medicine: Neurofibromatosis Type 1 Tumors: Natural History To Precision Therapy
Jointly sponsored by FAES and NIH, the Demystifying Medicine course aims to bridge exciting developments in medicine with advances in the basic biological and engineering sciences. When possible, a live patient introduces the course topic by discussing their disease, followed by a physician scientist who describes clinical aspects of the disease including therapy and challenges, followed by bench scientist who describes what we know and don't know regarding mechanism. The course is designed to excite as well as inform medical and Ph.D. students, fellows, basic and physician scientists, and program planners.For more informa...
Source: Videocast - All Events - December 21, 2021 Category: General Medicine Tags: Upcoming Events Source Type: video
2022 Demystifying Medicine Lecture Series: Neurofibromatosis Type 1 Tumors: Natural History To Precision Therapy
Jointly sponsored by FAES and NIH, the Demystifying Medicine course aims to bridge exciting developments in medicine with advances in the basic biological and engineering sciences. When possible, a live patient introduces the course topic by discussing their disease, followed by a physician scientist who describes clinical aspects of the disease including therapy and challenges, followed by bench scientist who describes what we know and don't know regarding mechanism. The course is designed to excite as well as inform medical and Ph.D. students, fellows, basic and physician scientists, and program planners.For more informa...
Source: Videocast - All Events - December 9, 2021 Category: General Medicine Tags: Upcoming Events Source Type: video
Advancing Therapies for Neurofibromatosis Type 1 (NF1): Lessons Learned from Every Patient
This is the annual Astute Clinician Lecture. Speaker Brigitte Widemann, M.D., is Chief, Pediatric Oncology Branch; Head, Pharmacology and Experimental Therapeutics Section; CCR Deputy Director, NCI. Refer to https://irp.nih.gov/pi/brigitte-widemann for an overview of her research. Co-sponsored by the NIH Clinical Center.For more information go tohttps://oir.nih.gov/walsAir date: 12/8/2021 3:00:00 PM (Source: Videocast - All Events)
Source: Videocast - All Events - September 10, 2021 Category: General Medicine Tags: Upcoming Events Source Type: video
Advancing Therapies for Children and Adults with Rare Tumors or Genetic Tumor Predisposition Syndromes
This is the annual G. Burroughs Mider Lecture. Speaker Brigitte Widemann, M.D., is the chief of the National Cancer Institute ’ s Pediatric Oncology Branch. Trained as a pediatric oncologist with expertise in drug development and early clinical trials for children with refractory cancers she applied her expertise to study genetic tumor predisposition syndromes (GTPS), in particular neurofibromatosis type 1 (NF1) and very rare pediatric and adult solid tumors.For more information go tohttps://oir.nih.gov/walsAir date: 4/21/2021 3:00:00 PM (Source: Videocast - All Events)
Source: Videocast - All Events - February 10, 2021 Category: General Medicine Tags: Upcoming Events Source Type: video
Developing Therapies for Ras-Driven Tumors
NCI's Center for Cancer Research (CCR) Grand Rounds
Dr. Cichowski ’ s research goals are to elucidate mechanisms that drive human cancer, identify novel therapeutic targets, and generate robust animal models to facilitate these efforts. A related goal is to establish collaborative relationships with clinicians to translate basic scientific findings into clinical trials. Her principal scientific interest is to understand how the Ras pathway, which is deregulated in the majority of human cancers, promotes tumorigenesis. She and her colleagues have been investigating this question in nervous system tumors, prostate, lung, m...
Source: Videocast - All Events - October 16, 2017 Category: General Medicine Tags: Upcoming Events Source Type: video
